These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5612931)

  • 1. [The activity of fibrinase in cirrhosis of the liver and chronic hepatitis].
    Maliarovskiĭ VN
    Ter Arkh; 1967 Jan; 39(1):61-2. PubMed ID: 5612931
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of serum beta-glucuronidase in liver cirrhosis and chronic hepatitis].
    Kordac V; Jirsa M
    Cesk Gastroenterol Vyz; 1967 Jun; 21(4):216-9. PubMed ID: 6062303
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Walls WD; Losowsky MS
    Thromb Diath Haemorrh; 1969 Feb; 21(1):134-43. PubMed ID: 5773724
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transaminase activity in chronic hepatitis and liver cirrhosis].
    Vido I; Wildhirt E
    Munch Med Wochenschr; 1969 Feb; 111(6):277-81. PubMed ID: 5819088
    [No Abstract]   [Full Text] [Related]  

  • 6. Deproteinized calf-blood extract, and influence of fibrin stabilising factor (Factor XIII) activity in cirrhosis of the liver.
    Szirmai E
    Agressologie; 1968; 9(4):543-7. PubMed ID: 5749219
    [No Abstract]   [Full Text] [Related]  

  • 7. [External secretory function of the pancreas in chronic hepatitis and liver cirrhosis].
    Valenkevich LN
    Vrach Delo; 1968 Aug; 8():33-6. PubMed ID: 5741741
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular subunits and transamidase activity of factor XIII during disseminated intravascular coagulation in acute leukaemia.
    Rodeghiero F; Barbui T; Battista R; Chisesi T; Rigoni G; Dini E
    Thromb Haemost; 1980 Feb; 43(1):6-9. PubMed ID: 6996205
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amylolytic function of the pancreas in patients with chronic hepatitis and liver cirrhosis].
    Valenkevich LN
    Sov Med; 1970 Mar; 33(3):101-4. PubMed ID: 5419155
    [No Abstract]   [Full Text] [Related]  

  • 10. [Enzymes of the pancreas and small intestine in chronic hepatitis and liver cirrhosis].
    Valenkevich LN
    Klin Med (Mosk); 1969 Apr; 47(4):71-5. PubMed ID: 5371491
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of proteolytic factor in the etiology of duodenitis and jejunitis in chronic hepatitis and liver cirrhosis].
    Iakhontova OI
    Ter Arkh; 1976; 48(9):54-7. PubMed ID: 996767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity of the pancreatic enzymes in chronic hepatites and liver cirrhoses and their clinical significance].
    Valenkevich LN
    Ter Arkh; 1968 Oct; 40(10):77-9. PubMed ID: 5741366
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microsomal enzymes in chronic liver diseases].
    Escartin P; Rossi I; Díaz Gil JJ; Gosalvez M
    Rev Clin Esp; 1976 Aug; 142(4):309-17. PubMed ID: 788068
    [No Abstract]   [Full Text] [Related]  

  • 15. [Postoperative complications due to acquired factor XIII deficiency].
    Thies HA; Busch H; Koch G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):135-40. PubMed ID: 4173875
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physiopathological significance of the histochemistry of hepatic proteases in the study of chronic liver diseases].
    Gabrielescu E; Nicolaescu T
    Rev Int Hepatol; 1969; 19(4):191-203. PubMed ID: 5404528
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of serum lysozyme in patients with liver diseases].
    Haskovcová H; Paulík M; Fucíková T
    Cesk Gastroenterol Vyz; 1982 Oct; 36(7):388-92. PubMed ID: 7172262
    [No Abstract]   [Full Text] [Related]  

  • 18. A change in lactate dehydrogenase isoenzymes in chronic diseases of the liver.
    Bondar' ZA; Podymova SD; Burchakova GI
    Ter Arkh; 1968 Dec; 40(12):57-62. PubMed ID: 5746544
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the influence of natural and synthetic antifibrinolytic agents on the determination of the fibrin stabilizing factor (factor 13)].
    Vogel G; Sundermann A; König B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):179-81. PubMed ID: 4174656
    [No Abstract]   [Full Text] [Related]  

  • 20. [The significance of the blood coagulation factor for the determination of the albumin synthesizing capability of the liver in parenchymal injury and for the operative risk in patients with liver cirrhosis].
    Esser G; Egli H; Kalinke H
    Acta Hepatosplenol; 1970; 17(3):159-65. PubMed ID: 4192798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.